PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
20-Aug-2021 Human Bone Marrow-derived Mononuclear Cells and Their Applications AcceGen
19-Aug-2021 Antimicrobial Susceptibility Testing Market Growth And Business Intelligence MarketsandMarkets
17-Aug-2021 Cidara Therapeutics and Mundipharma Announce Completion of Enrollment in the Phase 3 ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis Mundipharma
17-Aug-2021 Corvus Pharmaceuticals Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-818 in China Corvus Pharmaceuticals
13-Aug-2021 Velocity Clinical Research strengthens management team amid European expansion Velocity Clinical Research
12-Aug-2021 Biotium launches optimized solution for exosome detection by flow cytometry Biotium
12-Aug-2021 MeiraGTx Reports Second Quarter 2021 Financial and Operational Results MeiraGTx Holdings plc
11-Aug-2021 PONVORY®▼ (ponesimod), a Once Daily, Oral Therapy Authorised in Great Britain for the Treatment of Adults with Relapsing Forms of Multiple Sclerosis (RMS) with Active Disease Defined by Clinical or Imaging Features Janssen
11-Aug-2021 Amplity’s Blended Engagement Model: A New Post-COVID Health Care Provider (HCP) Customer Engagement Model for Pharma Amplity Health
11-Aug-2021 PHS Health Solutions Unveils Company Rebrand to Amplity Health Amplity Health
11-Aug-2021 Amplity Health Acquires RealHealthData Amplity Health
11-Aug-2021 Amplity Health’s Remote Engagement Center Is Named J.D. Power Certified Amplity Health’s
11-Aug-2021 SCYNEXIS and Amplity Health Announce Agreement to Support the Anticipated U.S. Commercialization of BrexafemmeTM (Ibrexafungerp) for Vaginal Yeast Infections Amplity Health
11-Aug-2021 Amplity’s Chief People Officer Named Delaware Valley Chief Human Resource Officer of the Year Amplity Health
11-Aug-2021 Advanced Clinical Continues Global Expansion into Europe with Ireland Office Advanced Clinical
11-Aug-2021 New Two-Year Data Showed Bimekizumab Maintained High Levels of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis UCB
10-Aug-2021 The Scottish Medicines Consortium recommends Merck & Pfizer’s Bavencio® (avelumab) as Monotherapy for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma (Bladder Cancer) Merck
09-Aug-2021 SCOTTISH MEDICINES CONSORTIUM (SMC) ACCEPTS TREMFYA®▼ (GUSELKUMAB), THE FIRST IL-23 p19 INHIBITOR TREATMENT, FOR ACTIVE PSORIATIC ARTHRITIS (PsA) Janssen
06-Aug-2021 Reference to Potential SRA737 Opportunity in Sierra Oncology Investor Call SAREUM HOLDINGS PLC
06-Aug-2021 CD BioSciences Launches ISS and ISE Study Design Services for Clinical Trials CD BioSciences